Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for UniPharma Co., Ltd. (6621.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
0.00
P/B ratioShare price divided by book value per share.
2.26
P/S ratioMarket value divided by annual revenue.
5.31
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
50.86%
Operating marginRevenue left after operating costs.
-62.61%
Net marginRevenue left after every cost, including tax and interest.
-47.80%
Return on equityProfit as a percentage of shareholders’ equity.
-17.90%
Return on assetsProfit as a percentage of total assets.
-10.86%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
4.85
Quick ratioThe same, excluding inventory.
3.77
Debt to equityTotal borrowings against shareholders’ equity.
0.06
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-1.13
Book value per shareShareholders’ equity divided by shares outstanding.
$5.54
Shares outstandingShares currently issued.
35,501,000
Market capitalisationShare price times shares outstanding.
$445.54M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
34
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.